573 related articles for article (PubMed ID: 901418)
1. Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.
White IN; Muller-Eberhard U
Biochem J; 1977 Jul; 166(1):57-64. PubMed ID: 901418
[TBL] [Abstract][Full Text] [Related]
2. Species differences in the hepatic formation of green pigments following the administration of norethindrone.
White IN; Boobis AR; Davies DS
Biochem Pharmacol; 1984 Feb; 33(3):459-64. PubMed ID: 6422948
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
[TBL] [Abstract][Full Text] [Related]
4. Destruction of cytochrome P-450 and formation of green pigments by contraceptive steroids in rat hepatocyte suspensions.
Blakey DC; White IN
Biochem Pharmacol; 1986 May; 35(9):1561-7. PubMed ID: 3707617
[TBL] [Abstract][Full Text] [Related]
5. Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomes.
Back DJ; Houlgrave R; Tjia JF; Ward S; Orme ML
J Steroid Biochem Mol Biol; 1991 Feb; 38(2):219-25. PubMed ID: 2004043
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives stimulate the excretion of clofibric acid glucuronide in women and female rats.
Liu HF; Magdalou J; Nicolas A; Lafaurie C; Siest G
Gen Pharmacol; 1991; 22(2):393-7. PubMed ID: 1905251
[TBL] [Abstract][Full Text] [Related]
7. Influence of norethindrone on drug-metabolizing enzymes of female rat liver in various B-vitamin deficiency states.
Wade AE; Evans JS
Pharmacology; 1977; 15(4):289-301. PubMed ID: 408827
[TBL] [Abstract][Full Text] [Related]
8. Liver function tests in patients on oral progestogens.
Engineer AD; Gupta V; Tandon P
J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
[TBL] [Abstract][Full Text] [Related]
9. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
Wild RA; Demers LM; Applebaum-Bowden D; Lenker R
Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
[TBL] [Abstract][Full Text] [Related]
10. In vitro steroid metabolic studies in human testes I: Effects of estrogen on progesterone metabolism.
Rodriguez-Rigau LJ; Tcholakian RK; Smith KD; Steinberger E
Steroids; 1977 Jun; 29(6):771-86. PubMed ID: 910250
[TBL] [Abstract][Full Text] [Related]
11. Reduction of the oral contraceptive estrogen burden by alternate day estrogen administration.
Segre EJ; Henzl MR; Giner J; Scheel C; Bessler S
Contraception; 1975 Aug; 12(2):155-74. PubMed ID: 1139955
[TBL] [Abstract][Full Text] [Related]
12. Problems in evaluating chronic toxicity of contraceptive steroids in dogs.
Weikel JH; Nelson LW
J Toxicol Environ Health; 1977 Sep; 3(1-2):167-77. PubMed ID: 72828
[TBL] [Abstract][Full Text] [Related]
13. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
14. Metabolic activation of acetylenic substituents to derivatives in the rat causing the loss of hepatic cytochrome P-450 and haem.
White IN
Biochem J; 1978 Sep; 174(3):853-61. PubMed ID: 728091
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
Kamal I; Zaki K; Rashad S
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
[TBL] [Abstract][Full Text] [Related]
16. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
Zaki K; Sami G; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
[TBL] [Abstract][Full Text] [Related]
17. Lack of influence of the phase of estrus cycle or treatment with steroid contraceptive drugs on cholinergic parameters in mouse and rat brain.
Ladinsky H; Consolo S; Bianchi S; Peri G; Garattini S
Pharmacology; 1976; 14(3):232-9. PubMed ID: 986656
[TBL] [Abstract][Full Text] [Related]
18. Studies on ethanol and oral contraceptives: feasibility of a hepatic-gonadal link.
Messiha FS; Lox CD; Heine W
Res Commun Subst Abuse; 1980; 1(3):315-33. PubMed ID: 12310979
[TBL] [Abstract][Full Text] [Related]
19. Use of Anovlar in gynaecological disorders and contraception.
Shahani SM; Chiklikar A
J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
[TBL] [Abstract][Full Text] [Related]
20. [The experimental studies on the estrogenic activities of 17alpha-ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one (ENT) (author's transl)].
Honjo H
Nihon Naibunpi Gakkai Zasshi; 1975 Sep; 51(9):705-23. PubMed ID: 1241851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
